NNNN Anbio Biotechnology Class A Ordinary Shares

100

Health Care [ 11/12 ] | Biotechnology [ 55/73 ]

NASDAQ | Common Stock

Price: $18.85

Increased by +17.08%
Dollar volume (20D): 867.10 K
ADR%: 10.83

Shares float: 0.00
Shares short: 0.00 [N/A%]
Shares outstanding: 0.00

Market cap: N/A
Beta: N/A
Price/earnings: N/A

20D range: 7.23 19.32
50D range: 5.90 19.32
200D range: 5.18 19.32

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products.

It serves over-the-counter, point-of-care testing, and laboratory markets.

The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Quarterly earnings
Annual earnings

Reported date	EPSChange YoY	EstimateSurprise

Quarterly financials
Annual financials

Fiscal ending date	RevenueChange YoY	IncomeChange YoY	ProfitChange YoY